Epigral informs about press release

05 May 2025 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral has informed that it enclosed Press Release for Audited Financial Results - Q4 & FY2025. The said Press Release is also available at www.epigral.com in the Investor Relations section.

The above information is a part of company’s filings submitted to BSE.

Epigral Share Price

1104.40 -42.50 (-3.71%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3580.50
Tata Chemicals 731.05
SRF 2873.15
Pidilite Inds. 1435.40
Deepak Nitrite 1603.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×